Parviz Hanjani
AuthID: R-00K-280
1
TÃTULO: Carboplatin and paclitaxel for advanced endometrial cancer: Final overall survival and adverse event analysis of a phase III trial (NRG Oncology/GOG0209)
AUTORES: David Scott Miller ; Virginia L Filiaci; Robert S Mannel; David E Cohn; Takashi Matsumoto; Krishnansu S Tewari; Paul DiSilvestro; Michael L Pearl; Peter A Argenta; Matthew A Powell; Susan L Zweizig; David P Warshal; Parviz Hanjani; Michael E Carney; Helen Huang; David Cella; Richard Zaino; Gini F Fleming;
PUBLICAÇÃO: 2020, FONTE: Journal of Clinical Oncology, VOLUME: 38, NÚMERO: 33
AUTORES: David Scott Miller ; Virginia L Filiaci; Robert S Mannel; David E Cohn; Takashi Matsumoto; Krishnansu S Tewari; Paul DiSilvestro; Michael L Pearl; Peter A Argenta; Matthew A Powell; Susan L Zweizig; David P Warshal; Parviz Hanjani; Michael E Carney; Helen Huang; David Cella; Richard Zaino; Gini F Fleming;
PUBLICAÇÃO: 2020, FONTE: Journal of Clinical Oncology, VOLUME: 38, NÚMERO: 33
2
TÃTULO: Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
AUTORES: David Scott Miller ; John A Blessing; Carolyn N Krasner; Robert S Mannel; Parviz Hanjani; Michael L Pearl; Steven E Waggoner; Cecelia H Boardman;
PUBLICAÇÃO: 2009, FONTE: Journal of Clinical Oncology, VOLUME: 27, NÚMERO: 16
AUTORES: David Scott Miller ; John A Blessing; Carolyn N Krasner; Robert S Mannel; Parviz Hanjani; Michael L Pearl; Steven E Waggoner; Cecelia H Boardman;
PUBLICAÇÃO: 2009, FONTE: Journal of Clinical Oncology, VOLUME: 27, NÚMERO: 16
